AEterna Zentaris To Present At Upcoming Canaccord Genuity 35th Annual Global Growth Conference In Boston
QUÉBEC CITY, Aug. 4, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Chairman and CEO, David Dodd, will be presenting a corporate overview at the Canaccord Genuity 35th Annual Global Growth Conference on Wednesday, August 12, 2015, at 11 am (Eastern), in the Melbourne Room of the Intercontinental Hotel in Boston.
A live audio and slide webcast of the presentation will be available via the Company's website at www.aezsinc.com in the "Newsroom" section, under "Events and Webcasts". A replay of the webcast will also be available on the Company's website for a period of 90 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. For more information, visit www.aezsinc.com.
SOURCE Aeterna Zentaris Inc.
Help employers find you! Check out all the jobs and post your resume.